275 related articles for article (PubMed ID: 28783691)
1. Characterization of T and B cell repertoire diversity in patients with RAG deficiency.
Lee YN; Frugoni F; Dobbs K; Tirosh I; Du L; Ververs FA; Ru H; Ott de Bruin L; Adeli M; Bleesing JH; Buchbinder D; Butte MJ; Cancrini C; Chen K; Choo S; Elfeky RA; Finocchi A; Fuleihan RL; Gennery AR; El-Ghoneimy DH; Henderson LA; Al-Herz W; Hossny E; Nelson RP; Pai SY; Patel NC; Reda SM; Soler-Palacin P; Somech R; Palma P; Wu H; Giliani S; Walter JE; Notarangelo LD
Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28783691
[TBL] [Abstract][Full Text] [Related]
2. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
3. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
4. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
[TBL] [Abstract][Full Text] [Related]
5. The Clinical and Genetic Spectrum of 82 Patients With
Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
Front Immunol; 2020; 11():900. PubMed ID: 32655540
[No Abstract] [Full Text] [Related]
6. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
[TBL] [Abstract][Full Text] [Related]
7. Genetically corrected RAG2-SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency.
Pavel-Dinu M; Gardner CL; Nakauchi Y; Kawai T; Delmonte OM; Palterer B; Bosticardo M; Pala F; Viel S; Malech HL; Ghanim HY; Bode NM; Kurgan GL; Detweiler AM; Vakulskas CA; Neff NF; Sheikali A; Menezes ST; Chrobok J; Hernández González EM; Majeti R; Notarangelo LD; Porteus MH
Blood Adv; 2024 Apr; 8(7):1820-1833. PubMed ID: 38096800
[TBL] [Abstract][Full Text] [Related]
8. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
9. RAG1 deficiency may present clinically as selective IgA deficiency.
Kato T; Crestani E; Kamae C; Honma K; Yokosuka T; Ikegawa T; Nishida N; Kanegane H; Wada T; Yachie A; Ohara O; Morio T; Notarangelo LD; Imai K; Nonoyama S
J Clin Immunol; 2015 Apr; 35(3):280-8. PubMed ID: 25739914
[TBL] [Abstract][Full Text] [Related]
10. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
11. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
12. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
[TBL] [Abstract][Full Text] [Related]
13. The recombinase activating genes: architects of immune diversity during lymphocyte development.
Braams M; Pike-Overzet K; Staal FJT
Front Immunol; 2023; 14():1210818. PubMed ID: 37497222
[TBL] [Abstract][Full Text] [Related]
14. Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.
Horowitz JE; Bassing CH
J Immunol; 2014 Feb; 192(4):1609-19. PubMed ID: 24415779
[TBL] [Abstract][Full Text] [Related]
15. Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.
Dorna MB; Barbosa PFA; Rangel-Santos A; Csomos K; Ujhazi B; Dasso JF; Thwaites D; Boyes J; Savic S; Walter JE
Front Pediatr; 2019; 7():122. PubMed ID: 31058115
[TBL] [Abstract][Full Text] [Related]
16. Three faces of recombination activating gene 1 (RAG1) mutations.
Patiroglu T; Akar HH; Van Der Burg M
Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
[TBL] [Abstract][Full Text] [Related]
18. Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis.
Ulusoy E; Karaca NE; Azarsiz E; Berdeli A; Aksu G; Kutukculer N
J Clin Med Res; 2016 May; 8(5):379-84. PubMed ID: 27081423
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in understanding RAG deficiencies.
Gennery A
F1000Res; 2019; 8():. PubMed ID: 30800289
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
